Recent Analyst Forecasts and Stock Ratings
Fulcrum Therapeutics, Inc. FAQ's
Fulcrum Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Leerink Partners, H.C. Wainwright, RBC Capital, Stifel Nicolaus, Bank of America Securities in the past 90 days.